A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

NCT03306394 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

907

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Trifluridine/Tipiracil hydrochloride (S95005)

Sponsor

Institut de Recherches Internationales Servier

Collaborators

[object Object]